Published in Ann Rheum Dis on October 01, 1991
Differences in disease phenotype and severity in SLE across age groups. Lupus (2016) 1.02
Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol (2014) 0.93
Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis (1992) 0.86
Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int (2009) 0.85
Autoimmune diseases and reproductive aging. Clin Immunol (2013) 0.85
Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int (2006) 0.84
A rare case of systemic lupus erythematosus with chylous ascites and chylothorax. Case Rep Rheumatol (2013) 0.83
A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus. Semin Arthritis Rheum (2016) 0.81
Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis (2013) 0.80
Systemic lupus erythematosus in 50 year olds. Postgrad Med J (1992) 0.79
A case of very late-onset systemic lupus erythematosus and updated pooled analysis of late-onset cases in the literature. Rheumatol Int (2011) 0.79
Serum cryoglobulins and disease activity in systematic lupus erythematosus. J Res Med Sci (2013) 0.75
Less disease severity and favorable prognosis are associated with postmenopausal systemic lupus erythematosus patients. Rheumatol Int (2008) 0.75
An uncommon cause of fever in the elderly: late-onset systemic lupus erythematosus. Clin Rheumatol (2003) 0.75
Systemic lupus erythematosus arising in a patient with chronic silicosis. Rheumatol Int (1997) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol (1985) 3.38
Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum (1982) 1.71
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol (1987) 1.59
Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol (1984) 1.27
Late onset systemic lupus erythematosus. Am J Med (1979) 1.25
Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology (1975) 1.16
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis (1990) 1.14
Systemic lupus erythematosus in the elderly. Arch Intern Med (1972) 1.08
Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol (1987) 1.07
Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum (1981) 1.06
Connective tissue disease in the elderly. Clin Rheum Dis (1986) 1.03
False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol (1988) 1.03
Systemic lupus erythematosus in the elderly. J Rheumatol Suppl (1987) 0.94
Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis. Scand J Rheumatol (1984) 0.94
The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol (1988) 0.90
SLE in the elderly--is it really SLE or systemic Sjögren's syndrome? J Rheumatol (1988) 0.89
Occult systemic lupus erythematosus in elderly men. JAMA (1983) 0.85
Systemic lupus erythematosus in the older age group: computer analysis. J Am Geriatr Soc (1979) 0.81
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med (2001) 5.95
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet (1998) 4.16
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum (1998) 4.00
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci (1999) 3.45
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
An anorexic lipid mediator regulated by feeding. Nature (2001) 2.94
A conserved RNA structure (thi box) is involved in regulation of thiamin biosynthetic gene expression in bacteria. Proc Natl Acad Sci U S A (2001) 2.88
Renal injury in the extremely obese patients with normal renal function. Kidney Int (2008) 2.83
Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med (1998) 2.68
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (1997) 2.50
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol (2000) 2.06
Vatican approves use of animal transplants 'to benefit humans'. Nature (2001) 2.03
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases]. Med Clin (Barc) (1994) 2.03
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
[50 years of LE cells: is it time for their retirement?]. Med Clin (Barc) (1998) 2.02
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) (2001) 1.97
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol (2009) 1.81
Standardized approach for microsatellite instability detection in colorectal carcinomas. J Natl Cancer Inst (2000) 1.80
Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer (1988) 1.74
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation (1991) 1.68
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) (2004) 1.68
High-resolution PLA-based composite scaffolds via 3-D printing technology. Acta Biomater (2012) 1.67
Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med (1994) 1.67
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis (1998) 1.55
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus (1997) 1.52
International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod (1993) 1.51
Feasibility of early discharge after acute Q wave myocardial infarction in patients not receiving thrombolytic treatment. J Am Coll Cardiol (1993) 1.48
[Primary Sjögren's syndrome and lymphatic proliferation]. Med Clin (Barc) (2000) 1.47
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
alpha-Interferon therapy for congenital dyserythropoiesis type I. Br J Haematol (1995) 1.46
Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol (1999) 1.44
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.42
[Management of myocardial infarction in Spain (1995-99). Data from the registry of the Ischaemic Heart Disease Working Group (RISCI) of the Spanish Society of Cardiology]. Rev Esp Cardiol (2001) 1.42
[Variability in the management and prognosis at short- and medium-term of myocardial infarct in Spain: the PRIAMHO study. Registration Project of Hospital Acute Myocardial Infarct]. Rev Esp Cardiol (1999) 1.42
[Credibility-based medicine]. Rev Esp Cardiol (2001) 1.41
Feasibility and prognostic value of dobutamine-atropine stress echocardiography early in unstable angina. Eur Heart J (2000) 1.41
Transcatheter aortic valve replacement (TAVR) in patients with systemic autoimmune diseases. Lupus (2013) 1.41
[Functional abnormality of the diaphragm in the "shrinking lung" in systemic lupus erythematosus]. Rev Clin Esp (1993) 1.40
[Intolerance to hydroxychloroquine marketed in Spain (Dolquine) in patients with autoimmune conditions]. Rev Clin Esp (2004) 1.40
Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study. Rev Clin Esp (Barc) (2013) 1.40
Impaired response of atrial natriuretic factor to blood volume expansion in acute right ventricular infarction. Am J Cardiol (1991) 1.40
[Libman-Sacks endocarditis and anticardiolipin antibodies]. Med Clin (Barc) (1989) 1.39
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients]. Med Clin (Barc) (1997) 1.39
[Improvement in the treatment of acute myocardial infarct by the establishment of a thrombolysis unit in a cardiology servic]. Rev Esp Cardiol (1998) 1.39
Reengineering respiratory support following extubation: avoidance of critical care unit costs. Chest (1999) 1.39
Technical improvements in corrosion casting of small specimens: a study on mesonephric tubules and vessels of chicken embryos. Scanning Microsc (1993) 1.39
Spain closes the door on embryonic stem cell research. Lancet (2001) 1.38
[Fierce diagnosis and treatment]. Med Clin (Barc) (2001) 1.38
Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer (2000) 1.36
Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res (1999) 1.33
The lung in the antiphospholipid syndrome. Ann Rheum Dis (2002) 1.33
Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci (2000) 1.31
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Chagas disease in Latin American migrants: a Spanish challenge. Clin Microbiol Infect (2010) 1.27
Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy (2007) 1.27
Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer (2004) 1.27
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum (2010) 1.26
Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol (1991) 1.25
Comparison of clinical variables and variables derived from a limited predischarge exercise test as predictors of early and late mortality after myocardial infarction. J Am Coll Cardiol (1985) 1.24
Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis (2003) 1.22
Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) (1997) 1.22
Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthritis Rheum (1989) 1.21
Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol (1997) 1.20
PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene (1999) 1.19
Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) (2001) 1.17
Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer (1987) 1.17
The molecular karyotype of the megabase chromosomes of Trypanosoma brucei stock 427. Mol Biochem Parasitol (2000) 1.16